Raffi Asadorian - ACRX Old Chief Officer
ACRXDelisted Stock | USD 1.01 0.01 1.00% |
Executive
Mr. Raffi M. Asadorian was appointed as Chief Financial Officer of the company .He has served as Chief Financial Officer since August 2017. Previously, Mr. Asadorian served as the Chief Financial Officer of Amyris, Inc., a publicly traded commercialstage biotechnology company, from January 2015 to January 2017. Prior to Amyris, he served as the Chief Financial Officer of Unilabs, a private equityowned medical diagnostics company, from August 2009 to October 2014. Mr. Asadorian started his career at PricewaterhouseCoopers where he was a partner in its Transaction Services group. While at PwC, Mr. Asadorian advised Barr Pharmaceuticals, a publicly traded specialty pharmaceutical company, on its acquisition of PLIVA, a publicly traded pharmaceutical company, and, after its acquisition, Mr. Asadorian joined Barr as Senior Vice President and Chief Financial Officer of its PLIVA business from 2007 to 2009. In that role, Mr. Asadorian oversaw a global finance team and was responsible for Barrs exUS financial operations, until its acquisition by Teva Pharmaceuticals since 2017.
Age | 55 |
Tenure | 8 years |
Professional Marks | MBA |
Phone | 650 216 3500 |
Web | https://www.acelrx.com |
ACRX Old Management Efficiency
The company has return on total asset (ROA) of (0.3222) % which means that it has lost $0.3222 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5112) %, meaning that it created substantial loss on money invested by shareholders. ACRX Old's management efficiency ratios could be used to measure how well ACRX Old manages its routine affairs as well as how well it operates its assets and liabilities.ACRX Old currently holds 10.42 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. ACRX Old has a current ratio of 1.77, which is within standard range for the sector. Note, when we think about ACRX Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Thomas Pearl | Organogenesis Holdings | N/A | |
Robert Arnold | Aquestive Therapeutics | N/A | |
Steve Laninga | Lifecore Biomedical | N/A | |
Mitchell Gendel | Tilray Inc | 58 | |
John Sadler | Tilray Inc | N/A | |
Brikkelle Thompson | Lifecore Biomedical | N/A | |
DMD MD | Evoke Pharma | 76 | |
Matt Augustson | Lifecore Biomedical | N/A | |
Stephen Wargacki | Aquestive Therapeutics | 47 | |
Bill Iskos | Assertio Therapeutics | N/A | |
Jeff Christensen | Assertio Therapeutics | N/A | |
Randy Daigneau | Tilray Inc | N/A | |
Darren Hieber | Lifecore Biomedical | N/A | |
MD MBA | Assertio Therapeutics | N/A | |
Nyree Pinto | Tilray Inc | N/A | |
Jackie Klecker | Lifecore Biomedical | N/A | |
William CPA | Organogenesis Holdings | N/A | |
Kara Morley | Lifecore Biomedical | N/A | |
Marilyn Carlson | Evoke Pharma | 76 | |
Gene Esq | Shuttle Pharmaceuticals | N/A | |
Robert Cavorsi | Organogenesis Holdings | 46 |
Management Performance
Return On Equity | -0.51 | |||
Return On Asset | -0.32 |
ACRX Old Leadership Team
Elected by the shareholders, the ACRX Old's board of directors comprises two types of representatives: ACRX Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ACRX. The board's role is to monitor ACRX Old's management team and ensure that shareholders' interests are well served. ACRX Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ACRX Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
Vincent Angotti, CEO, Interim CFO | ||
Anil Dasu, Chief Officer | ||
Lawrence Hamel, Chief Devel. Officer | ||
Pamela MD, Chief CoFounder | ||
Raffi Asadorian, Chief Officer |
ACRX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ACRX Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.51 | |||
Return On Asset | -0.32 | |||
Operating Margin | (28.28) % | |||
Current Valuation | 3.25 M | |||
Shares Outstanding | 16.95 M | |||
Shares Owned By Insiders | 2.63 % | |||
Shares Owned By Institutions | 38.88 % | |||
Number Of Shares Shorted | 508.11 K | |||
Price To Earning | 0.39 X | |||
Price To Book | 0.74 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in ACRX Stock
If you are still planning to invest in ACRX Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACRX Old's history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stocks Directory Find actively traded stocks across global markets |